Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

sections

Issue : The Pharmaceutical Journal, 31 January 2015, Vol 294, No 7847

Sort by: Newest first Oldest first A-Z Z-A

  • Pharmacists can help reduce prescribing errors made by doctors in hospitals

    Helping reduce doctors' prescribing errors in hospitals

    8 JAN 2015 By Sophia Feret

    A study in 2009 found that prescribing error rates for junior doctors are around 9%. Education and training pharmacist Sophia Feret describes a scheme she devised to help reduce these errors.

  • Expensive treatments for hepatitis C will now be available to more patients. Pictured micrograph of hepatitis C virus

    More UK patients will now be eligible for two costly hepatitis C treatments Subscription

    16 JAN 2015 15:45 By Ingrid Torjesen

    Sofosbuvir has received the green light from NICE but will not be available to patients until August 2015, while simeprevir will only be accessible through a patient access scheme.

  • Patients should know who did the final check Subscription

    19 JAN 2015 9:41 By Kiran Parikh
    Comments (3)

    I have had heated debates with dispensing staff about patients’ right to know if a pharmacist has performed the final check and bagged their medicines. Certainly, if I were a patient, I would like to know who is doing the final check of my medicines.

  • Voltarol OTC tablets recalled Subscription

    19 JAN 2015 11:11

    Following the decision from the Medicines and Healthcare products Regulatory Agency (MHRA) to make oral medicines containing diclofenac available only on prescription, Voltarol Pain-eze tablets, Voltarol Pain-eze Extra Strength tablets 25mg  and Voltarol Joint Pain tablets 12.5mg will no longer available for sale over the counter and are being recalled. There are no plans at this time to relaunch these products as prescription-only medicines. Topical products, such as Voltarol Paineze ...

  • Assisted dying laws Subscription

    19 JAN 2015 13:04

    14 January 2015: The Times and The Scotsman reported that Holyrood was considering new laws to allow assisted dying in Scotland. They focused on the fact that “doctors in Scotland have demanded a ‘conscience clause’ be inserted into new laws on assisted suicide”.

  • Cost of cancer drugs Subscription

    19 JAN 2015 16:06

    Elizabeth Sukkar, deputy news editor of The Pharmaceutical Journal, talked to BBC Radio Leicester about the cost of cancer drugs and cost of developing new medicines.

  • David Taylor, pharmacist, academic and one of the top clinical leaders in Britain in 2014

    Answering clinical conundrums as a psychiatry research leader Subscription

    19 JAN 2015 16:35 By Stephen Robinson

    Pharmacist and academic David Taylor, lead author of ‘The Maudsley prescribing guidelines’, was named as one of the top clinical leaders in Britain in 2014. He discusses why he believes pharmacy’s future lies in clinical aspects of care and research.

  • Light micrograph of liver sarcoidosis, a non-malignant immunological disorder characterised by non-caseating (non-necrotising) granulomas.

    Identifying and managing sarcoidosis Subscription

    20 JAN 2015 By Lloyd Mayers, Sarah Mulholland

    Sarcoidosis is a complex immunological disorder that requires careful management and vigilant monitoring.

  • The Cancer Drugs Fund has undermined the National Institute for Health and Care Excellence and has provided a “get out of jail card” for pharmaceutical companies.

    Cancer Drugs Fund has undermined NICE, its chair admits Subscription

    20 JAN 2015 17:10 By Janna Lawrence

    The Cancer Drugs Fund has undermined the National Institute for Health and Care Excellence and has provided a “get out of jail card” for pharmaceutical companies, its chair says.

  • Audit highlights problem of patients taking NSAIDs without gastroprotection Subscription

    21 JAN 2015 9:54

    Many patients taking non-steroidal anti-inflammatory drugs are not co-prescribed gastroprotective agents, an audit of community pharmacies in England has found.

Show  10 per page20 per page50 per page

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.